Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Language
Year range
1.
Gayathri Nagaraj; - COVID-19 and Cancer Consortium; Shaveta Vinayak; Ali Raza Khaki; Tianyi Sun; Nicole M. Kuderer; David M. Aboulafia; Jared D. Acoba; Joy Awosika; Ziad Bakouny; Nicole B. Balmaceda; Ting Bao; Babar Bashir; Stephanie Berg; Mehmet A. Bilen; Poorva Bindal; Sibel Blau; Brianne E. Bodin; Hala T. Borno; Cecilia Castellano; Horyun Choi; John Deeken; Aakash Desai; Natasha Edwin; Lawrence E. Feldman; Daniel B. Flora; Christopher R. Friese; Matthew D. Galsky; Cyndi Gonzalez Gomez; Petros Grivas; Shilpa Gupta; Marcy Haynam; Hannah Heilman; Dawn L. Hershman; Clara Hwang; Chinmay Jani; Sachin R. Jhawar; Monika Joshi; Virginia Kaklamani; Elizabeth J. Klein; Natalie Knox; Vadim S. Koshkin; Amit A. Kulkarni; Daniel H. Kwon; Chris Labaki; Philip E. Lammers; Kate I. Lathrop; Mark A. Lewis; Xuanyi Li; Gilbert de Lima Lopes; Gary H. Lyman; Della F. Makower; Abdul-Hai Mansoor; Merry-Jennifer Markham; Sandeep H. Mashru; Rana R. McKay; Ian Messing; Vasil Mico; Rajani Nadkarni; Swathi Namburi; Ryan H. Nguyen; Taylor Kristian Nonato; Tracey Lynn O'Connor; Orestis Panagiotou; Kyu Park; Jaymin M. Patel; Kanishka GopikaBimal Patel; Jeffrey Peppercorn; Hyma Polimera; Matthew Puc; Yuan James Rao; Pedram Razavi; Sonya A. Reid; Jonathan W. Riess; Donna R. Rivera; Mark Robson; Suzanne J. Rose; Atlantis D. Russ; Lidia Schapira; Pankil K. Shah; M. Kelly Shanahan; Lauren C. Shapiro; Melissa Smits; Daniel G. Stover; Mitrianna Streckfuss; Lisa Tachiki; Michael A. Thompson; Sara M. Tolaney; Lisa B. Weissmann; Grace Wilson; Michael T. Wotman; Elizabeth M. Wulff-Burchfield; Sanjay Mishra; Benjamin French; Jeremy L. Warner; Maryam B. Lustberg; Melissa K. Accordino; Dimpy Shah.
medrxiv; 2023.
Preprint in English | medRxiv | ID: ppzbmed-10.1101.2023.03.09.23287038

ABSTRACT

Title: Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study Background: Limited information is available for patients with breast cancer (BC) and coronavirus disease 2019 (COVID-19), especially among underrepresented racial/ethnic populations. Methods: This is a COVID-19 and Cancer Consortium (CCC19) registry-based retrospective cohort study of females with active or history of BC and laboratory-confirmed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection diagnosed between March 2020 and June 2021 in the US. Primary outcome was COVID-19 severity measured on a five-level ordinal scale, including none of the following complications, hospitalization, intensive care unit admission, mechanical ventilation, and all-cause mortality. Multivariable ordinal logistic regression model identified characteristics associated with COVID-19 severity. Results: 1,383 female patient records with BC and COVID-19 were included in the analysis, the median age was 61 years, and median follow-up was 90 days. Multivariable analysis revealed higher odds of COVID-19 severity for older age (aOR per decade, 1.48 [95% CI, 1.32 - 1.67]); Black patients (aOR 1.74; 95 CI 1.24-2.45), Asian Americans and Pacific Islander patients (aOR 3.40; 95 CI 1.70 - 6.79) and Other (aOR 2.97; 95 CI 1.71-5.17) racial/ethnic groups; worse ECOG performance status (ECOG PS [≥]2: aOR, 7.78 [95% CI, 4.83 - 12.5]); pre-existing cardiovascular (aOR, 2.26 [95% CI, 1.63 - 3.15])/pulmonary comorbidities (aOR, 1.65 [95% CI, 1.20 - 2.29]); diabetes mellitus (aOR, 2.25 [95% CI, 1.66 - 3.04]); and active and progressing cancer (aOR, 12.5 [95% CI, 6.89 - 22.6]). Hispanic ethnicity, timing and type of anti-cancer therapy modalities were not significantly associated with worse COVID-19 outcomes. The total all-cause mortality and hospitalization rate for the entire cohort was 9% and 37%, respectively however, it varied according to the BC disease status. Conclusions: Using one of the largest registries on cancer and COVID-19, we identified patient and BC related factors associated with worse COVID-19 outcomes. After adjusting for baseline characteristics, underrepresented racial/ethnic patients experienced worse outcomes compared to Non-Hispanic White patients. Funding: This study was partly supported by National Cancer Institute grant number P30 CA068485 to Tianyi Sun, Sanjay Mishra, Benjamin French, Jeremy L. Warner; P30-CA046592 to Christopher R. Friese; P30 CA023100 for Rana R McKay; P30-CA054174 for Pankil K. Shah and Dimpy P. Shah; and the American Cancer Society and Hope Foundation for Cancer Research (MRSG-16-152-01 -CCE) and P30-CA054174 for Dimpy P. Shah. REDCap is developed and supported by Vanderbilt Institute for Clinical and Translational Research grant support (UL1 TR000445 from NCATS/NIH). The funding sources had no role in the writing of the manuscript or the decision to submit it for publication. Clinical trial number: CCC19 registry is registered on ClinicalTrials.gov, NCT04354701.


Subject(s)
Coronavirus Infections , Diabetes Mellitus , Neoplasms , Breast Neoplasms , COVID-19
2.
Arthaniti: Journal of Economic Theory and Practice ; : 09767479211065970, 2022.
Article in English | Sage | ID: covidwho-1673758

ABSTRACT

Women entrepreneurs have been facing various challenges in the sustenance of their enterprises. During the COVID-19 lockdown in India, their vulnerability doubled due to the financial distress. In the backdrop of this, the paper measures the direct and indirect impact via forward and backward linkages of women entrepreneurs during the COVID-19 lockdown. Further, it examines their sustainability and the challenges they faced during the lockdown. The paper is based on primary data using a pre-structured questionnaire from 50 women entrepreneurs in Rishikesh, Uttarakhand. Analyses have been performed using principal components analysis, Kruskal?Wallis H test, Mann?Whitney U test and Chi-square test. The paper exhibits that both the direct and indirect impacts via forward and backward linkages have been more significant on women entrepreneurs. However, women entrepreneurs tried to sustain their business by switching towards online conduct of business, changing their promotional strategy and doing work from home. A major challenge faced by them is the lack of finance, and they relied on their previous savings to finance the expenditure.JEL Codes: L25, L26

SELECTION OF CITATIONS
SEARCH DETAIL